Imipenem (Primaxin) is an intravenous β-lactam antibiotic developed in 1980. It has an extremely broad spectrum of activity.[citation needed]Imipenem belongs to the subgroup of carbapenems. It is derived from a compound called thienamycin which is produced by the bacterium Streptomyces cattleya. Imipenem has a broad spectrum of activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria.
This page contains content from the copyrighted Wikipedia article "Imipenem"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
